Cohort modeling study demonstrates high accuracy of a nomogram predicting sarcopenia in non-obese older adults, suggesting improved early clinical screening.
INTRODUCTION: Sarcopenia is common in older adults, with distinct features in non-obese individuals. This study developed and validated a nomogram to predict sarcopenia risk specifically in non-obese older adults. METHODS: Data from 1,654 CHARLS participants were used for model development and internal validation, and 263 NHANES participants for external validation. LASSO regression selected predictors. A nomogram was constructed and assessed using AUC (discrimination), calibration curves (accuracy), and decision curve analysis (clinical utility). RESULTS: Seven variables were included in the final nomogram: age, sex, BMI, hemoglobin (Hb), difficulty rising from a chair, history of falls, and basic living ability. The model demonstrated excellent discrimination, with an AUC of 0.88 (95% CI: 0.86-0.90) in the training set. Performance remained robust in the internal (AUC 0.89, 95% CI: 0.85-0.92) and external (AUC 0.94, 95% CI: 0.91-0.97) validation sets. In the sex-stratified analysis, age, BMI, BUN, liver diseases, and basic living ability were included in the male model (AUC: 0.95, 95% CI: 0.93-0.97). For females, age, BMI, creatinine (Cr), difficulty running 1 km, and basic living ability were included (AUC: 0.83, 95% CI: 0.79-0.87). All models demonstrated good calibration and clinical utility. CONCLUSION: This study established an effective and simple prediction model for sarcopenia in non-obese older adults. This nomogram can serve as a valuable clinical tool for the early identification and proactive management of sarcopenia in this specific population.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: